These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

662 related items for PubMed ID: 19446621

  • 1. Insulin-micro- and nanoparticles for pulmonary delivery.
    Klingler C, Müller BW, Steckel H.
    Int J Pharm; 2009 Jul 30; 377(1-2):173-9. PubMed ID: 19446621
    [Abstract] [Full Text] [Related]

  • 2. Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method.
    You Y, Zhao M, Liu G, Tang X.
    J Pharm Pharmacol; 2007 Jul 30; 59(7):927-34. PubMed ID: 17637186
    [Abstract] [Full Text] [Related]

  • 3. The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery.
    Zhang Y, Zhu J, Tang Y, Chen X, Yang Y.
    Drug Dev Ind Pharm; 2009 Sep 30; 35(9):1059-65. PubMed ID: 19640250
    [Abstract] [Full Text] [Related]

  • 4. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
    Ungaro F, d'Emmanuele di Villa Bianca R, Giovino C, Miro A, Sorrentino R, Quaglia F, La Rotonda MI.
    J Control Release; 2009 Apr 02; 135(1):25-34. PubMed ID: 19154761
    [Abstract] [Full Text] [Related]

  • 5. Inhaled insulin--does it become reality?
    Siekmeier R, Scheuch G.
    J Physiol Pharmacol; 2008 Dec 02; 59 Suppl 6():81-113. PubMed ID: 19218634
    [Abstract] [Full Text] [Related]

  • 6. Nano-salbutamol dry powder inhalation: a new approach for treating broncho-constrictive conditions.
    Bhavna, Ahmad FJ, Mittal G, Jain GK, Malhotra G, Khar RK, Bhatnagar A.
    Eur J Pharm Biopharm; 2009 Feb 02; 71(2):282-91. PubMed ID: 18984050
    [Abstract] [Full Text] [Related]

  • 7. Fabrication of inhalable spore like pharmaceutical particles for deep lung deposition.
    Shen ZG, Chen WH, Jugade N, Gao LY, Glover W, Shen JY, Yun J, Chen JF.
    Int J Pharm; 2012 Jul 01; 430(1-2):98-103. PubMed ID: 22486960
    [Abstract] [Full Text] [Related]

  • 8. Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery.
    Pilcer G, Vanderbist F, Amighi K.
    Int J Pharm; 2009 Jan 05; 365(1-2):162-9. PubMed ID: 18782609
    [Abstract] [Full Text] [Related]

  • 9. Pulmonary delivery of therapeutic peptides via dry powder inhalation: effects of micronisation and manufacturing.
    Irngartinger M, Camuglia V, Damm M, Goede J, Frijlink HW.
    Eur J Pharm Biopharm; 2004 Jul 05; 58(1):7-14. PubMed ID: 15207532
    [Abstract] [Full Text] [Related]

  • 10. Microencapsulated chitosan nanoparticles for lung protein delivery.
    Grenha A, Seijo B, Remuñán-López C.
    Eur J Pharm Sci; 2005 Jul 05; 25(4-5):427-37. PubMed ID: 15893461
    [Abstract] [Full Text] [Related]

  • 11. Formulation and in vitro evaluation of highly dispersive insulin dry powder formulations for lung administration.
    Depreter F, Amighi K.
    Eur J Pharm Biopharm; 2010 Nov 05; 76(3):454-63. PubMed ID: 20797437
    [Abstract] [Full Text] [Related]

  • 12. Pulmonary delivery of insulin by liposomal carriers.
    Huang YY, Wang CH.
    J Control Release; 2006 Jun 12; 113(1):9-14. PubMed ID: 16730838
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics and pharmacodynamics of controlled release insulin loaded PLGA microcapsules using dry powder inhaler in diabetic rats.
    Hamishehkar H, Emami J, Najafabadi AR, Gilani K, Minaiyan M, Hassanzadeh K, Mahdavi H, Koohsoltani M, Nokhodchi A.
    Biopharm Drug Dispos; 2010 Mar 12; 31(2-3):189-201. PubMed ID: 20238376
    [Abstract] [Full Text] [Related]

  • 14. Particle engineering using sonocrystallization: salbutamol sulphate for pulmonary delivery.
    Dhumal RS, Biradar SV, Paradkar AR, York P.
    Int J Pharm; 2009 Feb 23; 368(1-2):129-37. PubMed ID: 18996462
    [Abstract] [Full Text] [Related]

  • 15. Nanoparticle formulations in pulmonary drug delivery.
    Bailey MM, Berkland CJ.
    Med Res Rev; 2009 Jan 23; 29(1):196-212. PubMed ID: 18958847
    [Abstract] [Full Text] [Related]

  • 16. Dry powder aerosol delivery of large hollow nanoparticulate aggregates as prospective carriers of nanoparticulate drugs: effects of phospholipids.
    Hadinoto K, Phanapavudhikul P, Kewu Z, Tan RB.
    Int J Pharm; 2007 Mar 21; 333(1-2):187-98. PubMed ID: 17084567
    [Abstract] [Full Text] [Related]

  • 17. Comparison of physical and inhalation properties of spray-dried and micronized terbutaline sulphate.
    Thi TH, Danède F, Descamps M, Flament MP.
    Eur J Pharm Biopharm; 2008 Sep 21; 70(1):380-8. PubMed ID: 18504120
    [Abstract] [Full Text] [Related]

  • 18. Physical characteristics and aerosol performance of naringin dry powders for pulmonary delivery prepared by spray-drying.
    Sansone F, Aquino RP, Del Gaudio P, Colombo P, Russo P.
    Eur J Pharm Biopharm; 2009 May 21; 72(1):206-13. PubMed ID: 18996478
    [Abstract] [Full Text] [Related]

  • 19. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.
    Cheow WS, Ng ML, Kho K, Hadinoto K.
    Int J Pharm; 2011 Feb 14; 404(1-2):289-300. PubMed ID: 21093560
    [Abstract] [Full Text] [Related]

  • 20. A novel spray-drying technique to produce low density particles for pulmonary delivery.
    Steckel H, Brandes HG.
    Int J Pharm; 2004 Jun 18; 278(1):187-95. PubMed ID: 15158961
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.